Home > Income Statement > VALIANT LABORATORIES

VALIANT LABORATORIES
Revenue

    Back to Income Statement
VALIANT LABORATORIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for VALIANT LABORATORIES
Please provide your vote to see the results

VALIANT LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Net Sales ₹237 Cr₹133 Cr₹182 Cr₹334 Cr

What is the latest Revenue of VALIANT LABORATORIES ?

The latest Revenue ratio of VALIANT LABORATORIES is ₹237 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹237 Cr
Mar2025₹133 Cr
Mar2024₹182 Cr
Mar2023₹334 Cr

How is Revenue of VALIANT LABORATORIES Trending?

Years Revenue % Change
Mar2026 ₹237 Cr
78.04
Mar2025 ₹133 Cr
-26.74
Mar2024 ₹182 Cr
-45.48
Mar2023 ₹334 Cr -

Compare Revenue of peers of VALIANT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VALIANT LABORATORIES ₹619.0 Cr -7.7% -2.6% 35.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹459,497.0 Cr 8.1% 9.3% 9% Stock Analytics
DIVIS LABORATORIES ₹294,146.0 Cr 10.5% 18% 51.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,474.0 Cr 2.9% 2.1% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹114,349.0 Cr -0.1% 16% 14.6% Stock Analytics
CIPLA ₹113,989.0 Cr 1.4% 8.1% -6.8% Stock Analytics


VALIANT LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VALIANT LABORATORIES

-7.7%

-2.6%

35.9%

SENSEX

7%

11.5%

-3.5%


You may also like the below Video Courses